Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 11 studies | 30% ± 10% | |
oligodendrocyte precursor cell | 9 studies | 27% ± 9% | |
astrocyte | 6 studies | 25% ± 8% | |
cardiac muscle cell | 4 studies | 23% ± 2% | |
fibroblast | 4 studies | 29% ± 6% | |
neuron | 3 studies | 24% ± 10% | |
hepatocyte | 3 studies | 51% ± 18% | |
Mueller cell | 3 studies | 19% ± 2% | |
glutamatergic neuron | 3 studies | 22% ± 7% | |
GABAergic neuron | 3 studies | 25% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 837.59 | 962 / 966 | 96% | 12.30 | 507 / 527 |
brain | 99% | 1043.34 | 2622 / 2642 | 96% | 14.51 | 676 / 705 |
skin | 97% | 1233.16 | 1760 / 1809 | 97% | 29.47 | 458 / 472 |
liver | 100% | 1424.51 | 226 / 226 | 93% | 11.58 | 378 / 406 |
esophagus | 94% | 817.44 | 1354 / 1445 | 96% | 20.36 | 175 / 183 |
kidney | 100% | 2020.54 | 89 / 89 | 88% | 14.41 | 796 / 901 |
prostate | 100% | 1288.24 | 244 / 245 | 89% | 8.55 | 445 / 502 |
lung | 98% | 699.58 | 569 / 578 | 88% | 9.97 | 1013 / 1155 |
thymus | 95% | 537.12 | 622 / 653 | 90% | 17.46 | 543 / 605 |
uterus | 100% | 1526.08 | 170 / 170 | 81% | 8.70 | 373 / 459 |
bladder | 100% | 849.10 | 21 / 21 | 79% | 8.09 | 396 / 504 |
stomach | 74% | 489.16 | 264 / 359 | 98% | 14.53 | 279 / 286 |
pancreas | 77% | 284.42 | 254 / 328 | 91% | 15.04 | 162 / 178 |
ovary | 92% | 591.31 | 165 / 180 | 75% | 7.54 | 322 / 430 |
breast | 92% | 505.87 | 420 / 459 | 71% | 7.85 | 789 / 1118 |
adrenal gland | 100% | 2638.54 | 258 / 258 | 59% | 8.91 | 135 / 230 |
muscle | 100% | 1839.60 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.51 | 1 / 1 |
blood vessel | 100% | 1321.89 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1849.03 | 847 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 14.75 | 74 / 80 |
adipose | 92% | 511.06 | 1106 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 79% | 13.81 | 23 / 29 |
tonsil | 0% | 0 | 0 / 0 | 64% | 6.39 | 29 / 45 |
spleen | 51% | 170.95 | 123 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 32% | 285.25 | 301 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097237 | Biological process | cellular response to toxic substance |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0003674 | Molecular function | molecular_function |
GO_0005515 | Molecular function | protein binding |
Gene name | ABTB2 |
Protein name | Ankyrin repeat and BTB/POZ domain-containing protein 2 |
Synonyms | |
Description | FUNCTION: May be involved in the initiation of hepatocyte growth. . |
Accessions | ENST00000435224.3 [Q8N961-1] Q8N961 |